VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.
Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis, the growth of new capillaries from existing microvasculature. In peripheral arterial disease (PAD), lower extremity muscle ischemia develops downstream of atherosclerotic obstruction. A working hypothesis proposed that the maladaptive overexpression of soluble VEGF receptor 1 (sVEGFR1) in ischemic muscle tissues, and its subsequent antagonism of VEGF bioactivity, may contribute to the deficient angiogenic response in PAD, as well as the limited success of therapeutic angiogenesis strategies where exogenous VEGF genes/proteins are delivered. The objectives of this study were to develop a computational framework for simulating the systemic distributions of VEGF and sVEGFR1 (e.g., intramuscular vs. circulating, free vs. complexed) as observed in human PAD patients and to serve as a platform for the systematic optimization of diagnostic tools and therapeutic strategies. A three-compartment model was constructed, dividing the human body into the ischemic calf muscle, blood, and the rest of the body, connected through macromolecular biotransport processes. Detailed molecular interactions between VEGF, sVEGFR1, endothelial surface receptors (VEGFR1, VEGFR2, NRP1), and interstitial matrix sites were modeled. Our simulation results did not support a simultaneous decrease in plasma sVEGFR1 during PAD-associated elevations in plasma VEGF reported in literature. Furthermore, despite the overexpression in sVEGFR1, our PAD control demonstrated increased proangiogenic signaling complex formation, relative to our previous healthy control, due to sizeable upregulations in VEGFR2 and VEGF expression, thus leaving open the possibility that impaired angiogenesis in PAD may be rooted in signaling pathway disruptions downstream of ligand-receptor binding.
Wu
Florence T H
FT
Dept. of Biomedical Engineering, Johns Hopkins Univ. School of Medicine, 720 Rutland Ave., 613 Traylor Research Bldg., Baltimore, MD 21205, USA. florence.wu@jhu.edu
Stefanini
Marianne O
MO
Mac Gabhann
Feilim
F
Kontos
Christopher D
CD
Annex
Brian H
BH
Popel
Aleksander S
AS
D002196:Capillaries / Q000378:metabolism; D006801:Humans; D007866:Leg / Q000098:blood supply; D008954:Models, Biological; D018482:Muscle, Skeletal / Q000098:blood supply / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000503:physiopathology; D039942:Neuropilin-1 / Q000378:metabolism; D016491:Peripheral Vascular Diseases / Q000378:metabolism* / Q000503:physiopathology; D012039:Regional Blood Flow / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000378:metabolism; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000378:metabolism*
D042461:Vascular Endothelial Growth Factor A; D039942:Neuropilin-1; D040281:Vascular Endothelial Growth Factor Receptor-1; D040301:Vascular Endothelial Growth Factor Receptor-2
PLoS Comput Biol. 2006 Dec 29;2(12):e180
17196035
Circ Res. 2007 Oct 26;101(9):948-56
17823371
Circ Res. 2008 Jun 20;102(12):1566-74
18515749
J Clin Invest. 1968 Sep;47(9):1973-99
5675423
J Am Coll Cardiol. 2009 Sep 29;54(14):1228-37
19778662
Biochemistry. 1989 Feb 21;28(4):1737-43
2541764
N Engl J Med. 2001 May 24;344(21):1608-21
11372014
Lab Invest. 2000 Apr;80(4):443-54
10780661
J Biol Chem. 2006 Feb 10;281(6):3604-13
16339148
Am J Physiol Heart Circ Physiol. 2005 Jan;288(1):H263-79
15331374
Am J Physiol Heart Circ Physiol. 2007 Jan;292(1):H459-74
16980341
J Appl Physiol (1985). 1999 Nov;87(5):1776-85
10562622
Arch Pathol Lab Med. 1977 Sep;101(9):500-3
578111
FASEB J. 2007 Dec;21(14):3896-903
17644610
J Appl Physiol (1985). 1996 Aug;81(2):780-8
8872646
Clin Sci (Lond). 2001 Sep;101(3):305-11
11524048
Clin Sci (Lond). 2005 Sep;109(3):227-41
16104843
Clin Sci (Lond). 2002 Feb;102(2):187-94
11834138
MAGMA. 1997 Jun;5(2):93-8
9268071
Biochem Biophys Res Commun. 1996 Sep 13;226(2):324-8
8806634
Ann N Y Acad Sci. 2009 Oct;1177:2-8
19845601
Anat Rec. 2000 Mar 1;258(3):305-18
10705351
Q J Exp Physiol. 1987 Oct;72(4):409-37
3321140
J Cell Mol Med. 2010 Mar;14(3):528-52
19840194
J Appl Physiol (1985). 2005 Jun;98(6):2137-46
15661835
J Physiol. 2007 Nov 15;585(Pt 1):231-9
17884919
Eur Heart J. 2006 Feb;27(3):310-5
16308326
Microcirculation. 2005 Jun;12(4):373-81
16020083
Angiogenesis. 1999;3(1):33-9
14517442
Lancet. 2001 Oct 13;358(9289):1257-64
11675083
Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1603-9
15920034
Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):185-92
9484982
Physiol Genomics. 2009 Jun 10;38(1):29-41
19351908
Eur J Vasc Endovasc Surg. 1996 May;11(4):409-13
8846172
Microcirculation. 2008 Nov;15(8):715-38
18608994
Diabetes. 2007 Mar;56(3):656-65
17327433
Biochemistry. 1982 Nov 23;21(24):6188-93
6217835
Curr Atheroscler Rep. 2001 May;3(3):225-33
11286644
Q J Nucl Med. 2003 Sep;47(3):149-61
12897707
J Am Coll Cardiol. 2008 Jul 29;52(5):387-93
18652948
Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3740-9
17890434
Clin Sci (Lond). 2001 May;100(5):567-75
11294698
J Biomech. 2005 Nov;38(11):2317-20
16154420
PLoS One. 2009;4(4):e5108
19352513
Mol Cancer Res. 2004 Jun;2(6):315-26
15235107
J Vasc Surg. 2005 May;41(5):802-7
15886664
Microcirculation. 2005 Sep;12(6):527-37
16147469
Endocr Rev. 1997 Feb;18(1):4-25
9034784
J Cell Sci. 2006 Aug 15;119(Pt 16):3467-80
16899821
J Gerontol A Biol Sci Med Sci. 2001 Jul;56(7):B302-10
11445595
Circulation. 1970 Feb;41(2):271-83
5412988
Circulation. 1993 Feb;87(2):413-21
8425290
Eur J Vasc Endovasc Surg. 2004 Jul;28(1):9-23
15177227
J Appl Physiol (1985). 1996 Mar;80(3):747-53
8964732
Biochem Biophys Res Commun. 2007 Apr 13;355(3):693-9
17320821
J Am Coll Cardiol. 2007 Mar 13;49(10):1015-26
17349880
Med Sci Sports Exerc. 2001 Dec;33(12):2016-21
11740293
Am J Physiol Heart Circ Physiol. 2005 Jun;288(6):H2785-91
15665063
J Physiol. 2003 Jul 1;550(Pt 1):217-25
12754306
BMC Syst Biol. 2008 Aug 19;2:77
18713470
J Biol Chem. 1983 Oct 10;258(19):11672-7
6225778
Ann Biomed Eng. 2004 May;32(5):645-63
15171620
J Vasc Surg. 2003 Nov;38(5):1067-74
14603219
Dev Dyn. 2001 Feb;220(2):112-21
11169844
J Biol Chem. 1997 Apr 18;272(16):10382-8
9099677
Circ Res. 2006 Oct 13;99(8):853-60
17008606
J Atheroscler Thromb. 2008 Feb;15(1):26-33
18270456
Physiol Rev. 1981 Jul;61(3):556-643
7019943
Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2646-52
18408130
J Biol Chem. 2000 Sep 1;275(35):26690-5
10842181
J Biol Chem. 2007 Dec 28;282(52):37585-96
17848556
Cell Mol Life Sci. 2006 Mar;63(5):601-15
16465447
Int Angiol. 2007 Jun;26(2):81-157
17489079
Ther Apher Dial. 2007 Jun;11(3):196-201
17498001
Clin Sci (Lond). 2003 Apr;104(4):397-404
12653684
Acta Physiol Scand. 1977 Feb;99(2):149-55
842371
J Am Coll Cardiol. 2006 Mar 7;47(5):921-9
16516072
J Vasc Surg. 2005 Aug;42(2):243-51
16102622
Nature. 2000 Sep 14;407(6801):249-57
11001068
Ann Vasc Surg. 1997 Jan;11(1):49-53
9061139
J Magn Reson Imaging. 2007 May;25(5):1013-20
17410566
J Vasc Interv Radiol. 2004 Nov;15(11):1197-207
15525738
IEEE Eng Med Biol Mag. 2009 Mar-Apr;28(2):14-31
19349248